Delving into the Latest Updates on Hong Kong Aomei Pharmaceutical Factory Co., Ltd. Beijing Representative Office with Synapse

Overview

Basic Info

Introduction

Hong Kong Aomei Pharmaceutical Factory Co., Ltd. Beijing Representative Office, incorporated in 1993, has its headquarters located in Hong Kong, China. This multinational pharmaceutical corporation is driven by its commitment to research and development, augmented by robust manufacturing and sales operations. The company maintains a sharp focus on six key therapeutic areas—dermatological health, bone health, pediatric health, respiratory health, gastrointestinal health, and neuro-mental health—striving to advance wellness in these domains.

Tags

Other Diseases

Skin and Musculoskeletal Diseases

Infectious Diseases

Herbal medicine

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Infectious Diseases	1

Top 5 Drug Type	Count

Herbal medicine	1
Small molecule drug	1

Top 5 Target	Count

PBPs(Bacterial penicillin-binding protein)	1

主要目的：本研究以澳美制药厂研发的骨化三醇软胶囊（规格：0.25 μg）为受试制剂，按生物等效性研究的有关规定，以原研厂家Roche Pharma (Schweiz) Ltd.生产的骨化三醇胶丸（规格：0.25 μg，商品名：罗盖全®）为参比制剂，评估受试制剂和参比制剂在空腹/餐后条件下给药后的生物等效性。次要研究目的：观察受试制剂骨化三醇软胶囊和参比制剂骨化三醇胶丸（罗盖全®）在健康受试者中的安全性。

[Translation]

Main purpose: This study uses the calcitriol soft capsule (specification: 0.25 μg) developed by Aome Pharmaceuticals as the test preparation. According to the relevant regulations of bioequivalence studies, the calcitriol capsule (specification: 0.25 μg, trade name: Roche Pharma (Schweiz) Ltd.) produced by the original manufacturer is used as the reference preparation to evaluate the bioequivalence of the test preparation and the reference preparation after administration under fasting/postprandial conditions. Secondary study objectives: To observe the safety of the test preparation calcitriol soft capsule and the reference preparation calcitriol capsule (Roche Pharma®) in healthy subjects.

Start Date13 Oct 2020

Sponsor / Collaborator

Hong Kong Aomei Pharmaceutical Factory Co., Ltd. Beijing Representative Office

CTR20191780 / Completed

酒石酸双氢可待因片随机、开放、两周期、交叉健康人体空腹/餐后状态下生物等效性试验

[Translation] A randomized, open-label, two-period, crossover bioequivalence study of dihydrocodeine tartrate tablets in healthy volunteers under fasting and fed conditions

本研究目的是比较两种酒石酸双氢可待因片30毫克在健康受试者空腹及餐后状态下的生物利用度，从而评估制剂的生物等效性。

[Translation]

The aim of this study was to compare the bioavailability of two dihydrocodeine tartrate tablets 30 mg in healthy volunteers in the fasting and fed state and to evaluate the bioequivalence of the formulations.

Start Date07 Aug 2019

Sponsor / Collaborator

Hong Kong Aomei Pharmaceutical Factory Co., Ltd. Beijing Representative Office

100 Clinical Results associated with Hong Kong Aomei Pharmaceutical Factory Co., Ltd. Beijing Representative Office

Login to view more data

0 Patents (Medical) associated with Hong Kong Aomei Pharmaceutical Factory Co., Ltd. Beijing Representative Office

Login to view more data

100 Deals associated with Hong Kong Aomei Pharmaceutical Factory Co., Ltd. Beijing Representative Office

Login to view more data

100 Translational Medicine associated with Hong Kong Aomei Pharmaceutical Factory Co., Ltd. Beijing Representative Office

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 28 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 1 Clinical

1

2

Other

Login to view more data